Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the
Russian Association of Gerontologists and Geriatricians and the National Society of Preventive …

Улучшение качества оказания медицинской помощи и увеличение продолжительности
жизни способствуют росту популяции пожилых и старых людей, что обусловливает …

[Ткачёва ОН—д. м. н., профессор, директор ФГАОУ ВО" Российский национальный
исследовательский медицинский университет им. НИ Пирогова" Минздрава России …

Contemporary medicine is shifting towards person rather than disease-oriented care. 1 With
increasing life expectancy and the ageing of baby boomers, the proportion over 60 years is …

Antithrombotic therapy represents the mainstay of treatment in patients with coronary artery
disease (CAD), including elderly patients who are at increased risk for ischemic recurrences …

Antithrombotic therapy represents the mainstay of treatment for prevention of recurrent
ischemic events in patients with atherothrombotic disease processes. Although the benefits …

Older individuals (subjects aged> 65 years) largely contribute to the percentage deaths due
to myocardial infarction (MI) and stroke. The incidence of venous thromboembolism (VTE) is …

The risk of venous thromboembolism increases with age. This increasing risk is associated
with a concurrent enhancement of coagulation activation and gradual development of a …

The first international guidance on antithrombotic therapy in the elderly came from the
European Society of Cardiology Working Group on Thrombosis in 2015. This same group …

Elderly people represent a patient population at high thromboembolic risk, but also at high
hemorrhagic risk. There is a general tendency among physicians to underuse …